Vikte Lionikaite1, Alistair S Curry1, Audrey E Brown1
Mathematics (Combinatorics) the Colombian Way: ECCO 2018
PDF) OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
Comparison of MERRA-2 and ECCO-v4 ocean surface heat fluxes: Consequences of different forcing feedbacks on ocean circulation an
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer. - Document - Gale Academic OneFile
Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice | Journal of Agricultural and Food Chemistry
European Crohn´s and Colitis Organisation - ECCO - The 13th Congress of ECCO in numbers
Discussion Late Breaking Abstracts (52298) | CRs | ena30 | ecco | meta-dcr
NASA ECCO - Meeting Documents (Detail)
Accepted Manuscript
Table of Contents page: European Journal of Cancer
PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
PDF) P275 Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experience
PDF) A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)
Julia Ulmschneider
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
Ultrathin Hafnium Disulfide Atomic Crystals with ROS-Scavenging and Colon-Targeting Capabilities for Inflammatory Bowel Disease Treatment | ACS Nano
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter
/wall-murals-polygon-abstract-background-vector.jpg.jpg "Wall Mural Polygon abstract background. Vector. - PIXERS.US")
Wall Mural Polygon abstract background. Vector. - PIXERS.US
European Crohn´s and Colitis Organisation - ECCO - ECCO Congress Abstracts
